Menu UF Health Home Menu
 

Recent Research

  • Richards, J, Gumz, M. Advances in Understanding the Peripheral Circadian Clocks. FASEB Journal (In Press).
  • Stow LR, Richards J, Cheng KY, Lynch IJ, Jeffers LA, Greenlee MM, Cain BD, Wingo CS, Gumz ML. The circadian protein period 1 contributes to blood pressure control and coordinately regulates renal sodium transport genes. Hypertension. 2012 Jun;59(6):1151-6. Epub 2012 Apr 23.
  • Jeffers LA, DiBartolo MC. Raising health care provider awareness of sexually transmitted disease in patients over age 50. Medsurg Nurs. 2011 Nov-Dec;20(6):285-9; quiz 290.
  • Ishimoto T, Lanaspa MA, Le MT, Garcia GE, Diggle CP, Maclean PS, Jackman MR, Asipu A, Roncal-Jimenez CA, Kosugi T, Rivard CJ, Maruyama S, Rodriguez-Iturbe B, Sánchez-Lozada LG, Bonthron DT, Sautin YY, Johnson RJ. Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc Natl Acad Sci U S A. 2012 109(11):4320-5
  • The circadian clock in the kidney. Stow LR, Gumz ML. J Am Soc Nephrol. 2011 Apr;22(4):598-604. Epub 2011 Mar 24. Review.
  • Regulation of αENaC expression by the circadian clock protein Period 1 in mpkCCD(c14) cells. Gumz ML, Cheng KY, Lynch IJ, Stow LR, Greenlee MM, Cain BD, Wingo CS. Biochim Biophys Acta. 2010 Sep;1799(9):622-9. Epub 2010 Sep 22.
  • “Thinking outside the clock box: Determining the mechanism of Per1 action in the kidney” presented by Dr. Michelle Gumz at the 52nd Annual Southern Salt, Water and Kidney Club Meeting in Lido Key, FL December 2011
  • Baldwin, W., S. McRae, G. Marek, D. Wymer, V. Pannu, Baylis C., Johnson R. J., and Sautin Y. Y. (2011) Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes (2011) 60(4):1258-69
  • Verlander JW, Hong S, Pech V, Bailey JL, Agazatian D, Matthews SW, Coffman TM, Le T, Inagami T, Whitehill FM, Weiner ID, Farley DB, Kim YH, Wall SM. Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin. Am J Physiol Renal Physiol. 2011 Dec;301(6):F1314-25. Epub 2011 Sep 14.
  • What is the role of using sodium thiosulfate or bisphosphonates in the treatment for calciphylaxis? Ross EA. Semin Dial. 2011 Jul-Aug;24(4):434-6.
  • Progesterone: not just a sex hormone anymore? Wingo CS, Greenlee MM. Kidney Int. 2011 Aug;80(3):231-3.
  • Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(ω)-nitro-L-arginine methyl ester hypertensive rats. Sasser JM, Molnar M, Baylis C. Hypertension. 2011 Aug;58(2):197-204.
  • Ultrafiltration for acute decompensated heart failure: Financial implications. Kazory A, Bellamy FB, Ross EA.Int J Cardiol. 2011 Jun 1.
  • Anaerobic clavicular osteomyelitis following colonoscopy in a hemodialysis patient. Kambhampati G, Asmar A, Pakkivenkata U, Ather IS, Ejaz AA. Clin Exp Nephrol. 2011 Oct;15(5):780-2.
  • Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study. Satoh M, Krzyszczak ME, Li Y, Ceribelli A, Ross SJ, Chan EK, Segal MS, Bubb MR, Sobel ES, Reeves WH. Arthritis Res Ther. 2011 May 10;13(3):R73.
  • Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide. McGuane JT, Debrah JE, Sautina L, Jarajapu YP, Novak J, Rubin JP, Grant MB, Segal M, Conrad KP. Endocrinology. 2011 Jul;152(7):2786-96. Epub 2011 May 10.
  • Ultrafiltration for acute decompensated heart failure: cost, reimbursement, and financial impact. Ross EA, Bellamy FB, Hawig S, Kazory A. Clin Cardiol. 2011 May;34(5):273-7. doi: 10.1002/clc.20913. Review.
  • Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species. Kirabo A, Kearns PN, Jarajapu YP, Sasser JM, Oh SP, Grant MB, Kasahara H, Cardounel AJ, Baylis C, Wagner KU, Sayeski PP. Cardiovasc Res. 2011 Jul 1;91(1):171-9. Epub 2011 Feb 24.
  • Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, Johnson RJ, Sautin YY. Diabetes. 2011 Apr;60(4):1258-69. Epub 2011 Feb 23.
  • A new form of myeloma “kidney”: shortened hemofilter survival and implications for membrane filtration plasmapheresis. Dana AP, Ahmar CA, Clapp WL, Ross EA. Clin Nephrol. 2011 Feb;75(2):120-4.
  • In vivo quantification of accumulating abdominal fluid using an electrical impedance tomography hemiarray. Tucker AS, Ross EA, Paugh-Miller J, Sadleir RJ. Physiol Meas. 2011 Feb;32(2):151-65. Epub 2010 Dec 22.
  • Mineralocorticoids stimulate the activity and expression of renal H+,K+-ATPases. Greenlee MM, Lynch IJ, Gumz ML, Cain BD, Wingo CS. J Am Soc Nephrol. 2011 Jan;22(1):49-58.
  • Role of NH3 and NH4+ transporters in renal acid-base transport. Weiner ID, Verlander JW. Am J Physiol Renal Physiol. 2011 Jan;300(1):F11-23.
  • Chronic vasodilation produces plasma volume expansion and hemodilution in rats: consequences of decreased effective arterial blood volume. Fekete A, Sasser JM, Baylis C. Am J Physiol Renal Physiol. 2011 Jan;300(1):F113-8. E
  • Regulation of αENaC expression by the circadian clock protein Period 1 in mpkCCD(c14) cells. Gumz ML, Cheng KY, Lynch IJ, Stow LR, Greenlee MM, Cain BD, Wingo CS. Biochim Biophys Acta. 2010 Sep;1799(9):622-9. Epub 2010 Sep 22.
  • Endothelin-1 gene regulation. Stow LR, Jacobs ME, Wingo CS, Cain BD. FASEB J. 2011 Jan;25(1):16-28.
  • Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis. Singh RP, Derendorf H, Ross EA. Clin J Am Soc Nephrol. 2011 May;6(5):1155-9.